Search for: "Noble v. Allness et al" Results 61 - 80 of 81
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Nov 2011, 11:03 am by Sean Wajert
Ford Motor Co. et al., No. 11-1665; Kerman et al. v. [read post]
30 Oct 2011, 8:59 pm by Schachtman
” Michele Carbone et al., “Modern Criteria to Establish Human Cancer Etiology,” 64 Cancer Res. 5518, 5522 (2004).) [read post]
17 Aug 2011, 2:00 am by Kara OBrien
” Furthermore, VC Noble found that the plaintiffs’ other claims relating to price, process and disclosure (including the disclosure of projections and additional detail regarding the financial advisors’ financial analyses)  were not colorable and denied the plaintiffs’ motion for expedited proceedings in all other respects. [read post]
21 Feb 2011, 9:25 am by Charon QC
It is fair to say that the noble Savage has become something of an Aunt Sally. [read post]
16 Jan 2009, 7:00 am
(IP Dragon) Patent strategies for foreign R&D work in China (Philip Brooks' Patent Infringement Updates) All clichés but still true: Intellectual Property Rights enforcement in China leaves room for improvement (IP Dragon) Recognition and protection of well-known trade marks (International Law Office) Revised Chinese patent law aims at quality, compulsory licensing (Intellectual Property Watch) Zen and the art of intellectual property in China (IP Dragon)  … [read post]
5 Dec 2008, 3:00 pm
(The Prior Art) Ways to avoid a USPTO ethics investigation (IP Updates)   US Patents – Decisions CAFC: Qualcomm penalised for failure to disclose patents to standard setting organisation and for litigation misconduct in failing to produce evidence: Qualcomm Inc v Broadcom Corp (IP Law Observer) (Patently-O) (Promote the Progress) (Law360) (Patent Prospector) (Hal Wegner) (PLI) CAFC upholds judgment enjoining inventor from asserting patent against Unitronics or its… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
13 Oct 2007, 7:52 am
I must, of course, leave this rather long post with a bit of Shakespeare - Henry V: O noble English! [read post]